The Moving Average Convergence Divergence (MACD) for NEO turned positive on October 27, 2026. Looking at past instances where NEO's MACD turned positive, the stock continued to rise in 39 of 48 cases over the following month. The odds of a continued upward trend are 81%.
Following a +6.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where NEO advanced for three days, in 216 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 55 cases where NEO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NEO as a result. In 65 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
NEO moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for NEO crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
NEO broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.754) is normal, around the industry mean (67.298). P/E Ratio (-43.179) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.189) is also within normal values, averaging (9.775).
The Tickeron Seasonality Score of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. NEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 70 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NNOX declined for three days, in 334 of 369 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for NNOX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NNOX's RSI Oscillator exited the oversold zone, 36 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 62 cases where NNOX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on NNOX as a result. In 76 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for NNOX just turned positive on November 10, 2026. Looking at past instances where NNOX's MACD turned positive, the stock continued to rise in 40 of 48 cases over the following month. The odds of a continued upward trend are 83%.
NNOX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.260) is normal, around the industry mean (4.142). P/E Ratio (-0.140) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.266) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. NNOX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NNOX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
NEO | NNOX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 27 | 96 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 27 Undervalued | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 99 | |
PRICE GROWTH RATING 1..100 | 36 | 97 | |
P/E GROWTH RATING 1..100 | 70 | 6 | |
SEASONALITY SCORE 1..100 | 31 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NEO's Valuation (27) in the Medical Or Nursing Services industry is in the same range as NNOX (41) in the null industry. This means that NEO’s stock grew similarly to NNOX’s over the last 12 months.
NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as NNOX (100) in the null industry. This means that NEO’s stock grew similarly to NNOX’s over the last 12 months.
NEO's SMR Rating (92) in the Medical Or Nursing Services industry is in the same range as NNOX (99) in the null industry. This means that NEO’s stock grew similarly to NNOX’s over the last 12 months.
NEO's Price Growth Rating (36) in the Medical Or Nursing Services industry is somewhat better than the same rating for NNOX (97) in the null industry. This means that NEO’s stock grew somewhat faster than NNOX’s over the last 12 months.
NNOX's P/E Growth Rating (6) in the null industry is somewhat better than the same rating for NEO (70) in the Medical Or Nursing Services industry. This means that NNOX’s stock grew somewhat faster than NEO’s over the last 12 months.
| NEO | NNOX | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 82% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 82% |
| Momentum ODDS (%) | 2 days ago 76% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 81% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 90% |
| Advances ODDS (%) | 3 days ago 78% | N/A |
| Declines ODDS (%) | 10 days ago 81% | 3 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 76% | 2 days ago 76% |
| Aroon ODDS (%) | N/A | 2 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NEO’s FA Score shows that 1 FA rating(s) are green while NNOX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NEO’s TA Score shows that 2 TA indicator(s) are bullish while NNOX’s TA Score has 5 bullish TA indicator(s).
NEO (@Medical Specialties) experienced а +0.77% price change this week, while NNOX (@Medical/Nursing Services) price change was +22.23% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.83%. For the same industry, the average monthly price growth was -5.05%, and the average quarterly price growth was +38.44%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.66%, and the average quarterly price growth was -1.83%.
NEO is expected to report earnings on Feb 23, 2027.
NNOX is expected to report earnings on Nov 19, 2026.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-2.76% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, NNOX has been loosely correlated with RDNT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NNOX jumps, then RDNT could also see price increases.
| Ticker / NAME | Correlation To NNOX | 1D Price Change % | ||
|---|---|---|---|---|
| NNOX | 100% | +59.80% | ||
| RDNT - NNOX | 46% Loosely correlated | -0.56% | ||
| TWST - NNOX | 44% Loosely correlated | -2.37% | ||
| SMTI - NNOX | 39% Loosely correlated | -1.37% | ||
| AZTA - NNOX | 38% Loosely correlated | -1.15% | ||
| NEO - NNOX | 37% Loosely correlated | -3.64% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RAAR | 51.79 | 0.05 | +0.09% |
| Reckoner Yield Enhanced AAA Clo Reinvesting ETF | |||
| USMD | 27.31 | N/A | N/A |
| Corevalues America First Technology ETF | |||
| GARY | 25.44 | -0.13 | -0.50% |
| Mango Growth ETF (GARY) | |||
| TAN | 43.51 | -1.67 | -3.70% |
| Invesco Solar ETF (TAN) | |||
| COHX | 10.46 | -1.03 | -8.96% |
| Tradr 2X Long COHR Daily ETF (COHX) | |||